Benign Masseteric Hypertrophy Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Ⅱ Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy
This study is A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax® in Subjects with Benign Masseteric Hypertrophy
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Ⅱ Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax® in Subjects with Benign Masseteric Hypertrophy ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04294251 -
Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
|
Phase 3 | |
Recruiting |
NCT05964257 -
To Evaluate the Efficacy and Safety of LIZTOX in Subjects With Benign Masseteric Hypertrophy
|
Phase 3 | |
Not yet recruiting |
NCT03369990 -
DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
|
Phase 2 |